This Article Full Text Full Text (PDF) Other Versions of this Article: CVI.00432-06v1 14/7/839    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhao, J. Articles by Gao, X.-M. Search for Related Content PubMed PubMed Citation Articles by Zhao, J. Articles by Gao, X.-M.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, July 2007, p. 839-846, Vol. 14, No. 7
1071-412X/07/$08.00+0     doi:10.1128/CVI.00432-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Comparison of Immunoglobulin G Responses to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients with SARS

Jincun Zhao,^1, Wei Wang,^1, Wenling Wang,¹ Zhendong Zhao,¹ Yan Zhang,¹ Ping Lv,¹ Furong Ren,² and Xiao-Ming Gao^1*

Department of Immunology, Peking University Health Science Center, Beijing, China,¹ Beijing Red Cross Blood Center, Beijing, China²

Received 16 November 2006/ Returned for modification 15 January 2007/ Accepted 22 April 2007

Both the nucleocapsid (N) and the spike (S) proteins of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) are able to induce strong humoral responses in humans following an infection. To compare the immunoglobulin G (IgG) responses to the S and N proteins of SARS-CoV in SARS patients during the manifestation/convalescent period with those during the postinfection period, serum samples were collected from hospitalized SARS patients within 6 weeks after the onset of illness (set 1; 57 sequential samples from 19 patients) or 2 to 3 months after their recovery (set 2; 33 postinfection samples from 33 subjects). Serum samples from 100 healthy blood donors (set 3), collected in 2002, were also included. The specific IgG response to whole virus, the fragment from positions 450 to 650 of the S protein (S450-650), and the full-length N protein of SARS-CoV were measured by enzyme-linked immunosorbent assays (ELISAs). Western blot assays were carried out to confirm the ELISA results. Fifty-one of the serum samples in set 1 (89%) bound to the N protein, a proportion similar to that which recognized whole virus (79%) and the S-protein fragment (77%). All 33 serum samples from set 2 were strongly positive for N-protein-specific IgG, while 27 (82%) were positive for anti-S450-650 IgG. Two of the serum samples from set 3 were strongly positive for anti-N-protein IgG but not anti-S450-650 IgG. Similar levels of IgG responses to the S and N proteins were observed in SARS patients during the manifestation and convalescent stages. In the postinfection period, however, a number of patients had much lower serum IgG levels against S450-650 than against the N protein.

Published ahead of print on 2 May 2007.

These two authors contributed equally to this work.

This article has been cited by other articles:

• Dijkman, R., Jebbink, M. F., El Idrissi, N. B., Pyrc, K., Muller, M. A., Kuijpers, T. W., Zaaijer, H. L., van der Hoek, L. (2008). Human Coronavirus NL63 and 229E Seroconversion in Children. J. Clin. Microbiol. 46: 2368-2373 [Abstract] [Full Text]